Meningococcal Polysaccharide Antigen Group A Uses, Dosage, Side Effects and more
Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.
| Attribute | Details |
|---|---|
| Trade Name | Meningococcal Polysaccharide Antigen Group A |
| Generic | Meningococcal polysaccharide vaccine group A |
| Meningococcal polysaccharide vaccine group A Other Names | Meningococcal group A polysaccharide, Meningococcal polysaccharide antigen group A, Neisseria meningitidis group A capsular polysaccharide antigen, Neisseria meningitidis group A polysaccharide antigen, A |
| Type | |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
